UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the Month of April 2019
333-206723
(Commission File Number)
P.V. Nano Cell Ltd.
(Exact name of Registrant as specified in its charter)
8 Hamasger Street
Migdal Ha’Emek, Israel 2310102
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover
Form 20-F or Form 40-F.
Form 20-F þ Form 40-F ☐
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(1): ____
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by
Regulation S-T Rule 101(b)(7): ____
On April 22nd, 2019, P.V. Nano Cell Ltd. (the “Issuer”) issued a press release announcing signing Agreement with Allen Woods & Associates for U.S. Sales and Distribution. Exhibit 99.1 and is incorporated herein by reference.
Exhibit Index
Exhibit No. | Description | |
99.1 | 2019-04-22_PV_Nano_Cell_Sign_Agreement_with_Allen_Woods_46 |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
P.V. Nano Cell Ltd. | ||
Date April 26th, 2019 | By: | /s/ Dr. Fernando de la Vega |
Name:
Dr. Fernando de la Vega Title: Chief Executive Officer |
2